ASX-listed Revasum sinks most in over a month as supply chain delays hit revenue
18/01/2022 02:13
** Shares of U.S.-based semiconductor maker Revasum Inc
RVS.AX slide as much as 11.2% to A$0.755, heading for their
worst session since Dec. 15
** Posts FY21 preliminary unaudited total revenue of $13.7
million, compared with $15.4 million in FY20 urn:newsml:reuters.com:*:nASX6jv7Gw
** "This was due to supply chain delays and our product
transition" - Revasum president and CEO Rebecca Shooter‐Dodd on
revenue fall
** Has a total order backlog of $8.7 million as of January
18, 2022, compared with $8.4 million as of Oct. 13; sees
increasing demand for its products
** RVS has added 34.9% this year as of last close
(Reporting by Harshita Swaminathan in Bengaluru)
((Harshita.Swaminathan@thomsonreuters.com))